Sobi announces positive Phase 2 NOBLE results of pegcetacoplan in post-transplant recurrence of primary IC-MPGN and C3G ...Middle East

PR Newswire - News
After 12 weeks, 50% of patients treated with pegcetacoplan showed a reduction in C3c staining by two or more orders of magnitude of intensity from baseline. Pegcetacoplan patients showed improvements across key clinical measures, including kidney function and proteinuria. No approved...

Hence then, the article about sobi announces positive phase 2 noble results of pegcetacoplan in post transplant recurrence of primary ic mpgn and c3g was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sobi announces positive Phase 2 NOBLE results of pegcetacoplan in post-transplant recurrence of primary IC-MPGN and C3G )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News